Chemotactic and suppressor cytokine networks

Hepato-Gastroenterology

Volumn 43, Issue 7, 1996, Pages 15-31

  Thompson, K ^a   Wright, S ^a   Sheron, N ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

CC chemokines; CXC chemokines; Hepatic inflammation; Interleukins; Transforming growth factor b1

Indexed keywords

CHEMOKINE; CYTOKINE; CYTOKINE RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 8; INTERLEUKIN DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; HEPATITIS; HUMAN; HUMAN CELL; KUPFFER CELL; LIVER CELL; LIVER CELL CULTURE; LIVER DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW;

ANIMALS; CELL COMMUNICATION; CHEMOKINES; CYTOKINES; HUMANS; INTERLEUKIN-10; INTERLEUKIN-13; INTERLEUKIN-4; INTERLEUKIN-8; LIVER; MICE; RECEPTORS, CYTOKINE; TRANSFORMING GROWTH FACTOR BETA;

EID: 0029863184     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (132)

1. Rot A: Neutrophil attractant/activation protein-1 (interleukin-8) induces in vitro neutrophil migration by mechanism. Eur. J. Immunol. 1993; 23: 303-306.
2. Webb LMC, Ehrengruber MU, Clarklewis I, Baggiolini M, Rot A: Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin-8. Proc. Natl. Acad. Sci. USA 1993; 90: 7158-7162.
3. Albano E, Goriagatti L, Clot P, Jannone A, Tomasi A: Possible role of free radical intermediates in hepatotoxicity of hydrazine derivatives. Toxicol. Ind. Health 1993; 9: 529-538.
4. Hermodson M, Schmer G, Kurachi J: Isolation, crystallization and primary amino acid sequence of PF4 J Biol Chem 1977; 252: 6276-6279.
5. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, Oppenheim JJ, Leonard EJ: Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc. Natl. Acad. Sci. USA 1987; 84: 9233-9237.
6. Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K: Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu. Rev. Immunol. 1991; 9: 617-648.
7. Yoshimura T, Robinson EA, Appella E, Matsushima K, Showalter SD, Skeel A, Leonard EJ: Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defence cytokines. Mol. Immunol. 1989; 26: 87-93.
8. Schroder JM, Sticherling M, Henneicke HH, Preissner WC, Christophers E: IL-1a or tumor necrosis factor-a stimulate release of three NAP-1/IL-8-related neutrophil chemotactic proteins in human dermal fibroblasts. J. Immunol. 1990; 144: 2223-2232.
9. Lindley I, Aschauer H, Seifert JM, Lam C, Brunowsky W, Kownatzki E, Thelen M, Peveri P, Dewald B, von Tsharner V, et al: Synthesis and expression in Escherichia coli of the gene encoding monocyte-derived neutrophil-activating factor: biological equivalence between natural and recombinant neutrophil-activating factor. Proc. Natl. Acad. Sci. USA 1988; 85: 9199-9203.
10. Baldwin ET, Weber IT, StCharles R, Xuan JC, Appella E, Yamada M, Matsushima K, Edwards BF, Clore GM, Gronenbor AMn et al: Crystal structure of interleukin 8: symbiosis of NMR and crystallography. Proc. Natl. Acad. Sci. USA 1991; 88: 502-506.
11. StCharles R, Walz DA, Edwards BF: The 3D structure of bovine PF4 at 3.0 ≈ resolution. J. Biol. Chem. 1989; 264: 2092-2099.
12. Mayo KH: Human PF4 monomer-dimer-tetramer equilibria investigated by 1H-NMR spectroscopy. Biochemistry 1991; 30: 925-934.
13. Mukaida N, Matsushima K: Regulation of IL-8 production and the characteristics of the receptors for IL-8. Cytokines. 1992; 4: 41-53.
14. Toledano MB, Ghosh D, Trinh F, Leonard WJ: N-terminal DNA binding domains contribute to differential DNA binding specificities of NF-kappa B p50 and p65. Mol. Cell. Biol. 1993; 13: 852-860.
15. Israel N, Gougerot Pocidalo MA, Aillet F, Virelizier JL: Redox status of cells influences constitutive or induced NF-k B translocation and HIV long terminal repeat activity in human T and monocytic cell lines. J. Immunol. 1992; 149: 3386-3393.
16. Meyer M, Pahl HL, Baeuerle PA: Regulation of transcription factors NF-kappa B and AP-1 by redox changes. Chem. Biol. Interact. 1994; 91: 91-100.
17. Geiser T, Dewald B, Ehrengruber MU, Clarklewis I, and Baggiolini M: The interleukin-8-related chemotactic cytokines GRO-a, GRO-b, and GRO-g activate human neutrophil and basophil leukocytes. J. Biol. Chem. 1993; 268: 15419-15424.
18. Proost P, De Wolf Peeters C, Conings R, Opdenakker C, Billiau A, Van Damme J: Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8. J. Immunol. 1993; 150: 1000-1010.
19. Walz A, Burgener R, Car B, Baggiolini M, Kunkel SL, Strieter RM: Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8. J. Exp. Med. 1991; 174: 1355-1362.
20. Walz A, Bagglioni M: Generation of NAP-2 from PBP or CTAP-111 through monocyte proteases. J. Exp. Med. 1990; 171: 449-454.
21. Luster AD, Ravetch JV: Biochemical characterization of a gamma interferon-inducible cytokine. J. Exp. Med. 1987; 166: 1084-1097.
22. Lipes MA, Napolitano M, Yeang KT, Chang NT, Leonard WJ: Identification, cloning and characterization of an immune activation gene. Proc. Natl. Acad. Sci. 1988; 85: 9704-9708.
23. Schall TJ, Jongstra J, Dyer KJ, Jorgensen J, Clayberger C, Davis MM, Krensky AM: A human T-cell specific molecule is a member of a new gene family. J. Immunol. 1988; 141: 1018-1025.
24. Voshimura T, Robinson EA, Tanaka S, Appella E, Leonard EJ: Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin-stimulated human blood mononuclear leukocytes. J. Immunol. 1989; 142: 1956-1962.
25. Miller MD, Krangel MS: Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit. Rev. Immunol. 1992; 12: 17-46.
26. Sorensen TI, Orholm M, Bentsen KD, Hoybye G, Eghoje K, Christoffersen P: Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis. Lancet 1984; 2: 241-244.
27. Balwit JM, Haak-Frendscho M, and Promega Corporation: Perspective Story: The chemokine network. Coordinate mediators of early inflammatory events. Promega Note 1993; 44: 34-39.
28. Gronenborn AM, Clore GM: Modeling the three-dimensional structure of the monocyte chemo-attractant and activating protein MCAF/MCP-1 on the basis of the solution structure of interleukin-8. Protein Eng. 1991; 4: 263-269.
29. Timmers HTM, Pronk GJ, Bos JL, Van der Eb AJ: Analysis of the rat JE gene promoter identifies an AP-1 binding site essential for basal expression but not for TPA induction. Nucleic Acid Res 1990; 18: 23-34.
30. Schall TJ: Biology of the RANTES/SIS cytokine family. Cytokine 1991; 3: 165-183.
31. Wolpe SD, Davatelis G, Sherry B, Beutler B, Hesse DG, Nguyen HT, Moldawer LL, Nathan CF, Lowry SF, Cerami A: Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J. Exp. Med. 1988; 167: 570-581.
32. Wang JM, Sherry B, Fivash MJ, Kelvin DJ, Oppenheim JJ: Human recombinant macrophage inflammatory protein-1 a and -b and monocyte chemotactic and activating factor utilize common and unique receptors on human monocytes. J Immunol 1993; 150: 3022-3029.
33. Baggiolini M, Dahinden CA: CC chemokines in allergic inflammation. Immunol Today 1994; 15: 127-133.
34. Wilson SD, Kuchroo VK, Israel DI, Dorf ME: Expression and characterization of TCA3: a murine inflammatory protein. J. Immunol. 1990; 145: 2745-2750.
35. Miller MD, Wilson SD, Dorf ME, Seuanez HN, O'Brien SJ, Krangel MS: Sequence and chromosomal location of the I-309 gene. Relationship to genes encoding a family of inflammatory cytokines. J. Immunol. 1990; 145: 2737-2744.
36. Kelvin DJ, Michiel DF, Johnston JA, Lloyd AR, Sprenger H, Oppenheim JJ, Wang JM: Chemokines and Serpentines - the molecular biology of chemokine receptors -review. J. Leukocyte Biol. 1993; 54: 604-612.
37. Holmes WE, Lee J, Kuang WJ, Rice GC, Wood WI: Structure and functional expression of a human interleukin-8 receptor. Science 1991; 253: 1278-1280.
38. Murphy PM, Tiffany HL: Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 1991; 253: 1280-1283.
39. Straufstatter IU, Barritt DS, Ma M, Oades ZG, Cochrane CG: Multiple sites on IL-8 responsible for binding to a and b IL-8 receptors. J. Immunol. 1993; 151: 6418-6428.
40. Kelvin DJ, Michiel DF, Johnslon JA, Lloyd AR, Sprenger H, Oppenheim JJ, Wang J: Chemokines and serpentines: the molecular biology of chemokine receptors. J. Leukoc. Biol. 1993; 54: 604-612.
41. Gao JL, Kuhns DB, Tiffany HL, Mcdermott D, Li X, Francke U, MurphY PM: Structure and functional expression of the human macrophage inflammatory protein 1-a/RANTES receptor J Exp Med 1993; 177: 1421-1427.
42. Yamagami S, Tokuda Y, Ishii K, Tanaka H, Endo N: cDNA cloning and functional expression of a human monocyte chemoattractant protein 1 receptor. Biochem. Biophys. Res. Commun. 1994; 202: 1156-1162.
43. Neote K, DiGregorio D, Mak JY, Horuk R, Schall TJ: Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 1993; 72: 415-425.
44. Neote K, Darbonne WC, Horuk R, Schall TJ: Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J. Biol. Chem. 1993; 268: 12247-12249.
45. Chaudhuri A, Polyakova J, Zbrzezna V, Williams K, Gulati S, Pogo AO: Cloning of glycoprotein cDNA, which enodes the major subunit of the Duffy blood group system and the receptor for the Plasmodium vivax malaria parasite. Proc. Natl. Acad. Sci. 1993; 90: 10793-10797.
46. Peters M, Liebman HA, Tong MJ, Tinberg HM: Alcoholic hepatitis: granulocyte chemotactic factor from Mallory body-stimulated human peripheral blood mononuclear cells. Clin Immunol. Immunopathol. 1983; 28: 418-430.
47. Perez HD, Roll FJ, Bissell DM, Shak S, Goldstein IM: Production of chemotactic activity for polymorphonuclear leukocytes by cultured rat hepatocytes exposed to ethanol. J. Clin. Invest. 1984; 74: 1350-1357.
48. Roll FJ, Bissell DM, Perez HD: Human hepatocytes metabolizing ethanol generate a non-polar chemotactic factor for human neutrophils. Biochem. Biophys. Res. Commun. 1986; 137: 688-694.
49. Roll FJ, Alexander M, Perez HD: Generation of chemotactic activity for neutrophils by liver cells metabolizing ethanol. Free Radic. Biol. Med. 1989; 7: 549-555.
50. Roll FJ, Alexander MA, Cua D, Swanson W, Perez HD: Metabolism of ethanol by rat hepatocytes results in generation of a lipid chemotactic factor: studies using a cell-free system and role of oxygen-derived free radicals. Arch. Biochem. Biophys. 1991; 287: 218-224.
51. Hultcrantz R, Bissell DM, Roll FJ: Iron mediates production of a neutrophil chemoattractant by rat hepatocytes metabolizing ethanol. J. Clin. Invest 1991; 87: 45-49.
52. Shiratori Y, Teraoka H, Matano S, Matsumoto K, Kamii K, Tanaka M: Kupffer cell function in chronic ethanol-fed rats. Liver 1989; 9: 351-359.
53. Shiratori Y, Takada H, Hai K, Kiriyama H, Nagura T, Tanaka M, Matsumoto K, Kamii K: Generation of chemotactic factor by hepatocytes isolated from chronically ethanol-fed rats. Dig. Dis. Sci. 1992; 37: 650-658.
54. Bogdan C, Paik J, Vodovotz Y, Nathan C: Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-b and interleukin-10. J Biol Chem. 1992; 267: 23301-23308.
55. Armendariz Borunda J, Seyer JM, Postlethwaite AE, Kang AH: Kupffer cells from carbon tetrachloride-injured rat livers produce chemotactic factors for fibroblasts and monocytes: the role of tumor necrosis factor-a. Hepatology 1991; 14: 895-900.
56. Thornton A J, Ham J, Kunkel SL: Kupffer cell-derived cytokines induce the synthesis of a leukocyte chemotactic peptide, interleukin-8, in human hepatoma and primary hepatocyte cultures. Hepatology 1991; 14: 1112-1122.
57. Sheron N, Bird G, Koskinas J, Portmann B, Ceska M, Lindley I, Williams R: Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. Hepatology 1993; 18: 41-46.
58. Sheron N, Ceska M, Lindley I, Williams R: Ethanol suppresses in vitro interleukin 8 synthesis production in Hep-G2 cells. J. Hepatol. 16(suppl 1992; 1): S61.
59. Maher JJ: Rat hepatocytes metabolizing ethanol provoke interkeukin 8 (CINC) secretion by rat Kupffer cells: A possible mechanism of alcoholic hepatitis. Hepatology 1994; 20: 270A.
60. Czaja MJ, Geerts A, Xu J, Schmiedeberg P, Ju Y: Monocyte chemoattractant protein 1 (MCP-1) expression occurs in toxic rat liver injury and human liver disease. J. Leuk. Biol. 1994; 55: 126.
61. Winwood PJ, Arthur MJP: Kupffer cells: their activation and role in animal models of liver injury and human liver disease. Semin. Liver Dis. 1993; 13: 50-59.
62. Decker K: Biologically active products of stimulated liver macrophages (Kupffer cells). Eur. J. Biochem. 1990; 192: 245-261.
63. Bouwens L, Baekeland M, Wisse E: Importance of local proliferation in the expanding Kupffer cell population of rat liver after zymosan stimulation and partial hepatectomy. Hepatology 1984; 4: 213-219.
64. Dieter P, Schulze-Specking A, Decker K: Release of lysosomal enzymes is not correlated with superoxide and prostaglandin production by stimulated rat Kupffer cells in primary cultures. J. Hepatol. 1988; 6: 167-174.
65. Itoh Y, Okanoue T, Morimoto M, Nagao Y, Mori T, Hori N, Kagawa K, Kashima K: Functional heterogeneity of rat liver macrophages: interleukin-1 secretion and Ia antigen expression in contrast with phagocytic activity. Liver 1992; 12: 26-33.
66. Ramadori G: Kupffer cells and fibrogenesis. In: Clement, B., A. Guillouzo (Eds.): Cellular and Molecular Aspects of Cirrhosis, pp. 169-176. Colloque INSERM/John Libbey Eurotext Ltd. 1992.
67. Phillips WA, Croatto M, Hamilton JA: The effect of interleukin-4 on the macrophage respiratory burst is species dependent. Biochem. Biophys. Res. Commun. 1992; 182: 727-732.
68. Mosmann TR: Regulation of immune responses by T cells with different cytokine secretion phenotypes: role of a new cytokine, cytokine synthesis inhibitory factor (IL10). Int. Arch. Allergy Appl. Immunol. 1991; 94: 110-115.
69. Moore KW, Vieira P, Fiorentino DF, Trounstine ML, Khan TA, Mosmann TR: Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science. 1990; 248: 1230-1234.
70. Bogdan C, Vodovotz Y, Nathan C: Macrophage deactivation by interleukin 10. J. Exp. Med. 1991; 174: 1549-1555.
71. Kim JM, Brannan CI, Copeland NG, Jenkins NA, Khan TA, Moore KW: Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J. Immunol. 1992; 148: 3618-3623.
72. Vieira P, De Waal Malefyt R, Dang MN, Johnson KE, Kastelein R, Fiorentino DF, deVries JE, Roncarolo MG, Mosmann TR, Moore KW: Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc. Natl. Acad. Sci. USA 1991; 88: 1172-1176.
73. Moore K, Rousset F, Banchereau J: Evolving principles in immunopathology: interleukin 10 and its relationship to Epstein-Barr virus protein BLRF-1. Springer Semin. Immunopathol. 1991; 13: 157-166.
74. De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE: Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp Med. 1991; 174: 1209-1220.
75. Wang P, Wu P, Siegel MI, Egan RW, Billah MM: IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J. Immunol. 1994; 153: 811-816.
76. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A: IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 1991; 147: 3815-3822.
77. Howard M, Muchamuel T, Andrade S, Menon S: Interleukin 10 protects mice from lethal endotoxemia. J Exp. Med. 1993; 177: 1205-1208.
78. Gerard C, Bruyns C, Marchant A, Abramowicz D, Vandenabeele P, Delvaux A, Fiers W, Goldman M, Velu T: Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp. Med. 1993; 177: 547-550.
79. Gazzinelli R T, Oswald IP, James SL, Sher A: IL-10 inhibits parasite killing and nitrogen oxide production by IFN-g-activated macrophages J Immunol 1992; 148: 1792-1796.
80. Cunha FQ, Moncada S, Liew FY: Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages Biochem Biophys Res Commun 1992; 182: 1155-1159.
81. Cenci E, Romani L, Mencacci A, Spaccapelo R, Schiaffella E, Puccetti P, Bistoni F: Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida-albicans. Eur. J. Immunol. 1993; 23: 1034-1038.
82. Oswald IP, Wynn TA, Sher A, James SL: Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor a required as a costimulatory factor for interferon gamma-induced activation. Proc. Natl. Acad. Sci. USA 1992; 89: 8676-8680.
83. Romani L, Puccetti P, Mencacci A, Cenci E, Spaccapelo R, Tonnetti L, Grohmann U, Bistoni F: Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. J. Immunol. 1994; 152: 3514-3521.
84. Nabioullin R, Sone S, Mizuno K, Yano S, Nishioka Y, Haku T, Ogura T: Interleukin-10 is a potent inhibitor of tumor cytotoxicity by human monocytes and alveolar macrophages. J. Leukocyte Biol. 1994; 55: 437-442.
85. Oswald IP, Gazzinelli RT, Sher A, JameS SL: IL-10 synergizes with IL-4 and transforming growth factor-b to inhibit macrophage cytotoxic activity J Immunol 1992; 148: 3578-3582.
86. De Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries JE: Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 1991; 174: 915-924.
87. Niiro H, Otsuka T, Kuga S, Nemoto Y, Abe M, Hara N, Nakano T, Ogo T, Niho Y: IL-10 inhibits prostaglandin E2 production by lipopolysaccharide-stimulated monocytes. Int. Immunol. 1994; 6: 661-664.
88. Mertz, PM, DeWitt DL, Stetler-Stevenson WC, Wahl LM: Interleukin-10 suppression of monocyte prostaglandin H synthase-2. J. Biol. Chem. 1994; 269(33): 21322-21329.
89. Mertz PM, DeWitt DL, Stetler Stevenson WG, Wahl LM: Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of prostaglandin-dependent matrix mettaloproteinase production. J. Biol. Chem. 1994; 269: 21322-21329.
90. Willens F, Marchant A, Delville JP, Gerard C, Delvaux A, Velu T, Deboer M, Goldman M: Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur. J. Immunol. 1994; 24: 1007-1009.
91. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W: Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75: 263-274.
92. Grewe M, Klein H, Decker K: Endotoxin induces IL-10 expression in Kupffer cells. In: Wisse, E., K. Wake, D. L. Knook (Eds.): Cells of the Hepatic Sinusoid. Kupffer Cell Foundation, 1995 (in press).
93. Grewe M, Gausling R, Gyufko K, Hoffmann R, Decker K: Regulation of the mRNA expression for tumor necrosis factor-a in rat liver macrophages. J. Hepatol. 1994; 20: 811-818.
94. Thai N L, Wang SC, Valdivia LA, Celli S, Reilly MJ, Demetris AJ, Simmons RL, Starzl TE, Fung JJ: Cytokine messenger RNA profiles in hamster-to-rat liver xenografts. Transplant. Proc. 1993; 25: 444-445.
95. Martinez O M, Krams SM, Sterneck M, Villanueva JC, Falco DA, Ferrell LD, Luke J, Roberts JP, Ascher NL: Intragraft cytokine profile during human liver allograft rejection. Transplantation 1992; 53: 449-456.
96. Shirwan H, Cosenza CA, Wang HK, Wu CD, Makowka L, Cramer DV: Prevention of orthotopic liver allograft rejection in rats with a short-term brequinar sodium therapy -analysis of intragraft cytokine gene expression. Transplantation 1994; 57: 1072-1080.
97. Sun J, Mccaughan GW, Matsumoto Y, Sheil AG, Gallagher ND, Bishop GA: Tolerance to rat liver allografts. I. Differences between tolerance and rejection are more marked in the B cell compared with the T cell or cytokine response. Transplantation 1994; 57: 1349-1357.
98. Lohr H F, Schlaak JF, Gerken G, Fleischer B, Dienes HP, Zumbuschenfelde KHM: Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T-lymphocytes from patients with chronic: hepatitis of different etiology. Liver 1994; 14: 161-166.
99. Cheever A W, Williams ME, Wynn TA, Finkelman FD, Seder RA, Cox TM, Hieny S, Caspar P, Sher A: Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis. J. Immunol. 1994; 153: 753-759.
100. Cook G A, Metwali A, Blum A, Mathew R, Weinstock JV: Lymphokine expression in granulomas of Schistosoma mansoni-infected mice. Cell. Immunol. 1993; 152: 49-58.
101. Miralles G D, Stoerkle MY, McDermott DF, Finkelman FD, Murray HW: Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis. Infect. Immun. 1994; 62: 1058-1063.
102. Wagner R D, Maroushek NM, Brown JF, Czuprynski CJ: Treatment with anti-interleukin-10 monoclonal antibody enhances early resistance to but impairs complete clearance of Listeria monocytogenes infection in mice. Infect. Immun. 1994; 62: 2345-2353.
103. Muller W, Rajewsky K, Kuhn R: Interleukin-4 deficient mice. Res. Immunol. 1993; 144(8): 637-638.
104. Zurawski G, deVries JE: Interleukin-13, an interleukin 4-like cytokine that acts on monocytes and B-cells, but not on T-cells. Immunol. Today 1994; 15: 19-26.
105. Zurawski C, deVries JE: Interleukin-13 elicits a subset of the activities of its dose relative interleukin-4. Stem Cells 1994; 12: 169-174.
106. Mosmann T R, Yokota T, Kastelin R, Zurawski S, Arai N, Takebe Y: Species-specificity of T cell stimulating activities of IL-2 and BSF-1 (1L-4): comparison of normal anf recombinant mouse and human IL-2 and BSF-1 (IL-4). J. Immunol. 1987; 138: 1813-1816.
107. Minty A, Chalon P, Derocq J-M, Dumont X, Guillemot J-C, et al: Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993; 362: 248-250.
108. Appelberg R, Orme IM, Pinto de Sousa MI, Silva MT: In vitro effects of interleukin-4 on interferon-g-induced macrophage activtion. Immunology 1992; 76: 553-559.
109. Ho J L, He SH, Rios MJ, Wick EA: Interleukin-4 inhibits human macrophage activation by tumor necrosis factor, granulocyte-monocyte colony-stimulating factor, interleukin-3 for anti-leishmanial activity and oxidative burst capacity. J. Infect. Dis. 1992; 165: 344-351.
110. Cox G W, Melillo G, Chattopadhyay U, Mullet D, Fertel RH, Varesio L: Tumor necrosis factor-a-dependent production of reactive nitrogen intermediates mediates IFN-g plus IL-2-induced murine macrophage tumoricidal activity. J. Immunol. 1992; 149: 3290-3296.
111. Sone S, Yanagawa H, Nishioka Y, Orino E, Bhaskaran G, Nii A, Mizuno K, Heike Y, Ogushi F, Ogura T: Interleukin-4 as a potent down-regulator for human alveolar macrophages capable of producing tumour necrosis factor-a and interleukin-1. Eur. Respir. J 1992; 5: 174-181.
112. Gautan S, Tebo JM, Hamilton TA: IL-4 suppresses cytokine gene expression induced by IFN-g and/or IL-2 in murine peritoneal macrophages. J. Immunol. 1992; 148: 1725-1730.
113. Doherty T M, Kastelein R, Menon S, Andrade S, Coffman RL: Modulation of murine macrophage function by IL-13. J. Immunol. 1993; 151: 7151-7160.
114. De Waal Malefyt R, Figdor CG, Huijbens R, Moha Sn Peterson, Bennett B, Culpepper J, Dang W, Zurawski G, de Vries JE: Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-g or IL-10. J. Immunol. 1993; 151: 6370-6381.
115. Wahl L M, Corcoran ML: Regulation of monocyte/macrophage metalloproteinase production by cytokines. J. Periodontol. 1993; 64: 467-473.
116. Lacraz S, Nicod L, Galve de Rochemonteix B, Baumberger C, Dayer JM, Welgus HG: Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J. Clin. Invest. 1992; 90: 382-388.
117. Doyle A G, Herbein G, Montaner LJ, Minty AJ, Caput D, Ferrara P, Gordon S: Interleukin-13 alters the activation state of murine macrophages in vitro: Comparison with interleukin-4 and interferon-g. Eur. J. Immunol. 1994; 24: 1441-1445.
118. Hart P H, Cooper RL, Finlay Jones JJ: IL-4 suppresses IL-1 b, TNF-a and PGE2 production by human peritoneal macrophages. Immunology 1991; 72: 344-349.
119. Standiford TJ, Strieter RM, Chensue SW, Westwick J, Kasahara K, Kunkel SL: IL-4 inhibits the expression of IL-8 from stimulated human monocytes. J. Immunol. 1990; 145: 1435-1439.
120. Brach M A, Gruss HJ, Riedel D, Asano Y, de Vos S, Herrmann F: Effect of antiinflammatory agents on synthesis of MCP-1/JE transcripts by human blood monocytes. Mol. Pharmacol. 1992; 42: 63-68.
121. Gautam S, Tebo JM, Hamilton TA: IL-4 suppresses cytokine gene expression induced by IFN-g and/or IL-2 in murine peritoneal macrophages J Immunol 1992; 148: 1725-1730.
122. Yamashita T, Boros DL: IL-4 influences IL-2 production and granulomatous inflammation in murine schistosomiasis mansoni. J. Immunol. 1992; 149: 3659-3664.
123. Lofer P, Ilyin G, Abde Zl Razzak, Banchereau J, Dezier JF, Campion JP, Guguen Guillouzo C, Guillouzo A: Interleukin 4 inhibits the production of some acute-phase proteins by human hepatocytes in primary culture. FEBS Lett. 1993; 336: 215-220.
124. Magilavy D B, Foys KM, Gajewski TF: Liver of MRL/lpr mice contain interleukin-4-producing lymphocytes and accessory cells that support the proliferation of Th2 helper T lymphocyte clones. Eur. J. Immunol. 1992; 22: 2359-2365.
125. Iizawa Y, Gzuprynski C: Effects of administration of murine recombinant IL-4 on the resistance of mice to Listeria monocytogenes infection. Immunol. Lett. 1992; 32: 185-189.
126. Haak Frendscho M, Brown JF, Iizawa Y, Wagner RD, Czuprynski CJ: Administration of anti-IL-4 monoclonal antibody 11B11 increases the resistance of mice to Listeria monocytogenes infection. J. Immunol. 1992; 148: 3978-3985.
127. Friedman S L: The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N. Engl. J. Med. 1993; 328: 1828-1835.
128. Bogdan C, Paik J, Vodovotz Y, Nathan C: Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-b and interleukin-10. J. Biol. Chem. 1992; 267: 23301-23308.
129. Shull M M, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annunziata N, Doetschman T: Targeted disruption of the mouse transforming growth factor-b1 gene results in multifocal inflammatory disease. Nature 1992; 359: 693-699.
130. Saperstein L A, Jirtle RL, Farouk M, Thompson HJ, Chung KS, Meyers WC: Transforming growth factor-b 1 and mannose 6-phosphate/insulin-like growth factor-II receptor expression during intrahepatic bile duct hyperplasia and biliary fibrosis in the rat. Hepatology 1994; 19: 412-417.
131. Kresina T F, He Q, Degli Exposti S, Zern MA: Hepatic fibrosis and gene expression changes induced by praziquantel treatment during immune modulation of Schistosoma japonicum infection. Parasitology 1993; 107: 397-404.
132. Geraci J P, Mariano MS: Radiation hepatology of the rat: parenchymal and nonparenchymal cell injury. Radiat. Res. 1993; 136: 205-213.